Advancements in Targeted Therapies for Vitiligo: Prioritizing Equity in Drug Development

Cutis. 2024 Apr;113(4):156-158. doi: 10.12788/cutis.0995.

Authors

Camile Delva¹, Todd F Pearson¹, John E Harris¹

Affiliation

¹ Camile Delva is from the CUNY School of Medicine, New York, New York. Drs. Pearson and Harris are from the Department of Dermatology, UMass Chan Medical School, Worcester.

PMID: 38820107
DOI: 10.12788/cutis.0995

No abstract available

MeSH terms

Dermatologic Agents / therapeutic use
Drug Development*
Humans
Molecular Targeted Therapy
Vitiligo* / drug therapy

Substances

Dermatologic Agents